DuPont launches high-dose vegetarian EPA omega-3 form
DuPont has launched a dietary supplement range in the US that employs its high-dose, yeast-derived EPA ingredient that is targeting younger consumers seeking vegetarian alternatives.
Archives for April 7, 2010
Raisio finalises UK snack food acquisition
Finland’s Raisio has announced it has finalised the acquisition of British snack foods manufacturer Glisten PLC, as the Finnish food manufacturer eyes opportunities for growth.
FDA food safety inspections and enforcement declining, auditors say
Federal inspections of food manufacturing facilities have declined over time, as have regulatory actions triggered by inspections, a government auditor reported on Wednesday.
Zinc may ease female anger and depression: Study
Daily supplements of zinc may reduce measures of anger and depression in young women, according to a new study from Japan.
Study finds antioxidants do not prevent pregnancy-associated hypertension
Taking vitamin C and E supplements starting in early pregnancy does not reduce the risk of hypertensive disorders such as pre-eclampsia that occur during pregnancy, according to a study published the New England Journal of Medicine.
Apples deserve superfruit status, say Americans
Americans believe apples should take their place alongside blueberries, cranberries and pomegranates as 21st century superfruit, according to a new market survey Apples: The Next Superfruit, prepared by SupermarketGuru.com and The Lempert Report.
CNI, Bio Serae owner shares innovation plans
The group behind ingredients firms CNI, Bio Serae, Afritec, Starlight Products and NutriProcess, has unveiled more details of its growth spurt strategy following the acquisition of 76 per cent of shares by its CEO, including a team dedicated to new...
Australia ponders herbal product restrictions
The ongoing rethinking of the rules governing herbal products in Australia has highlighted more than 30 herbs for safety review, according to the Therapeutic Goods Administration (TGA).
Krill pre-clinicals presented at symposia
Pre-clinical data showing a proprietary, pharma-grade krill extract called CaPre can benefit dyslipidemia and cardio-metabolic disorders, will be presented at American Heart Association meeting in San Francisco this week.